Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Acute Hamstring Strains
NCT02263729Phase 2Terminated
- Start
- Aug 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Hamstring Injury comparing Losartan with Placebo (2 arms). Primary endpoints: Reported Effects of Losartan for Hamstring Injury for Safety and Tolerability at 4 weeks, Recovery of Hamstring Muscle Function at 6 months and 3 more. Started Aug 2016; status: terminated.
02
Drugs
losartan
03
Conditions
Hamstring Injury
Beyond the preview
Go deeper on NCT02263729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263729.